N-(2,2,2-trifluoroethyl)piperidine-4-carboxamide hydrochloride, 95.0%, 500mg

4-(4-ethoxyphenyl)-3-(pyridin-3-yl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 250mg

3-Chloro-2-fluorothioanisole, 98%, 5g

4-[(4-bromo-3-fluorophenyl)methyl]-1?6-thiomorpholine-1,1-dione, 97.0%, 25g

3-(2-(3-(tert-Butoxy)-3-oxopropoxy)ethoxy)propanoic acid, 95%, 1g

Methyl 6-hydroxyhexanoate, 95.0%, 5g

5-Cyclopropylpyrazin-2-amine, 95%, 100mg

6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZIN-6-OL, 95%, 250mg

5-Ethoxy-6-methylpyridin-2-amine, 95.0%, 100mg

3-Nitro-5-iodobenzotrifluoride, 95.0%, 250mg

Anillos para trípode con apertura Variante, Ø interior (mm) 70, Ø exterior (mm), 87, Apertura (mm), 50, Longitud total (mm), 280, Longitud del eje (mm), 200, Empaquetado. (piezas),1

2-[4-[(4-CHLOROPHENYL)-PHENYLMETHYL]PIPERAZIN-1-YL]ETHANOL, 95.0%, 1g

2-Fenoxietanol, min 99%, para síntesis, 250 ml, envase de vidrio